The Sarah Cannon Research Institute joined Strata Oncology Inc.’s Precision Indications for Approved THerapies (NCT05097599) trial. Researchers will enroll patients at eight SCRI-affiliated sites including:
Florida Cancer Specialists (4 sites)Genesis Cancer and Blood Institute, Hot Springs, ARHematology Oncology Clinic, Baton Rouge, LATennessee Oncology, Chattanooga, TNZangmeister Cancer Center, Columbus, OH
